DK2408802T3 - Cykliske aminosyremolekyler og fremgangsmåder til fremstilling heraf - Google Patents

Cykliske aminosyremolekyler og fremgangsmåder til fremstilling heraf Download PDF

Info

Publication number
DK2408802T3
DK2408802T3 DK10753047.9T DK10753047T DK2408802T3 DK 2408802 T3 DK2408802 T3 DK 2408802T3 DK 10753047 T DK10753047 T DK 10753047T DK 2408802 T3 DK2408802 T3 DK 2408802T3
Authority
DK
Denmark
Prior art keywords
amino acid
peptide
cyclic
aryl
nmr
Prior art date
Application number
DK10753047.9T
Other languages
English (en)
Inventor
Andrei Yudin
Ryan Hili
Original Assignee
Governing Council Univ Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Governing Council Univ Toronto filed Critical Governing Council Univ Toronto
Application granted granted Critical
Publication of DK2408802T3 publication Critical patent/DK2408802T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/123—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (13)

1. Fremgangsmåde til dannelse af et cyklisk peptid, hvilken fremgangsmåde omfatter følgende trin: (i) omsætning afen aminendegruppe af et peptid eller en aminosyre med at aziridinaldehyd med følgende struktur:
(ii) omsætning af blandingen i trin (i) med et isocyanid.
2. Fremgangsmåde ifølge krav 1, hvor aziridinaldehydet er aziridinaldehydbisulfit.
3. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 2, hvor isocyanidet er tertiær-butyl isocyanid.
4. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor fremgangsmåden er en ettrinsfremgangsmåde.
5. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor omsætningerne finder sted under støkiometriske betingelser.
6. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvor omsætningen foretages med en aminosyre i vand.
7. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvilken fremgangsmåde yderligere omfatter følgende trin: (iii) omsætning af blandingen i trin (ii) med henblik på at åbne aziridinringen.
8. Fremgangsmåde ifølge krav 7, hvor blandingen i trin (ii) omsættes til en thioester.
9. Fremgangsmåde ifølge krav 7, hvorthiolsyren er thiobenzoesyre.
10. Fremgangsmåde ifølge et hvilket som helst af de foregående krav, hvilken fremgangsmåde yderligere omfatter det trin, at der inkorporeres fluorescerende mærker i det cykliske peptid ved nukleofil ringåbning af aziridingruppen.
11. Forbindelse ifølge nedenstående almene formel:
hvor, R1 og Rn hver især uafhængigt af hinanden er valgt fra en aminosyresidekædegruppe, og R2 er en alkylgruppe.
12. Forbindelse ifølge krav 11, hvor R2 er en tertiær-butylgruppe.
13. Forbindelse med en formel ifølge formel (I) til (VII):
DK10753047.9T 2009-03-16 2010-03-16 Cykliske aminosyremolekyler og fremgangsmåder til fremstilling heraf DK2408802T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16057109P 2009-03-16 2009-03-16
PCT/CA2010/000408 WO2010105363A1 (en) 2009-03-16 2010-03-16 Cyclic amino acid molecules and methods of preparing the same

Publications (1)

Publication Number Publication Date
DK2408802T3 true DK2408802T3 (da) 2017-08-28

Family

ID=42739085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10753047.9T DK2408802T3 (da) 2009-03-16 2010-03-16 Cykliske aminosyremolekyler og fremgangsmåder til fremstilling heraf

Country Status (11)

Country Link
US (2) US9260479B2 (da)
EP (1) EP2408802B1 (da)
JP (1) JP5866277B2 (da)
CN (1) CN102498124B (da)
AU (1) AU2010225426B2 (da)
CA (1) CA2756804C (da)
DK (1) DK2408802T3 (da)
ES (1) ES2634431T3 (da)
HK (1) HK1172036A1 (da)
PT (1) PT2408802T (da)
WO (1) WO2010105363A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012109735A1 (en) * 2011-02-17 2012-08-23 The Governing Council Of The University Of Toronto Methods of preparing cyclic amino acid molecules using arylboronic or arylborinic acid catalysts
EP2810069A4 (en) * 2012-02-03 2015-08-12 Univ Alberta METHOD FOR THE QUANTIFICATION OF PEPTIDE DERIVATIVE LIBRARIES BY PHAG DISPLAY
EP3221335A4 (en) * 2014-11-19 2018-06-27 Encycle Therapeutics, Inc. Solid phase synthesis of cyclic amino acid molecules
CN105087709B (zh) * 2015-08-20 2019-09-17 江苏省原子医学研究所 一种酶催化多组分反应合成环肽的方法
AU2016353547B9 (en) 2015-11-11 2020-12-03 Universite De Montreal Cyclic peptides targeting α4β7 integrin
CA3042576A1 (en) 2016-11-11 2018-05-17 Encycle Therapeutics, Inc. Cyclic peptides multimers targeting .alpha.4.beta.7 integrin
IL270465B (en) 2017-05-10 2022-09-01 Encycle Therapeutics Inc Cyclic peptides targeting alpha4beta7 integrin
US11174256B2 (en) 2018-10-30 2021-11-16 Gilead Sciences, Inc. Imidazopyridine derivatives
EP3873897B1 (en) 2018-10-30 2024-08-14 Gilead Sciences, Inc. N-benzoyl-phenylalanine derivatives as alpha4beta7 integrin inhibitors for treating inflammatory diseases
PE20211866A1 (es) 2018-10-30 2021-09-21 Gilead Sciences Inc Derivados de quinolina como inhibidores de la integrina alfa4beta7
WO2020092401A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
WO2021030438A1 (en) 2019-08-14 2021-02-18 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin
CN118440136A (zh) * 2024-05-08 2024-08-06 武昌理工学院 一种蛋白质赖氨酸选择性修饰的方法及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU638264B2 (en) * 1989-08-10 1993-06-24 Aventis Inc. Cyclic neurokinin a antagonists
US5705481A (en) * 1992-11-06 1998-01-06 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclopeptides
AU681119B2 (en) * 1993-05-17 1997-08-21 Fujisawa Pharmaceutical Co., Ltd. New polypeptide compound and a process for preparation thereof
US5693325A (en) * 1994-03-15 1997-12-02 Molecumetics, Ltd. Peptide vaccines and methods relating thereto
DE4415310A1 (de) * 1994-04-30 1995-11-02 Merck Patent Gmbh Cyclopeptide
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
US6492553B1 (en) * 1998-01-29 2002-12-10 Aventis Pharamaceuticals Inc. Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds
EP1745064B1 (en) * 2004-04-15 2011-01-05 Proteolix, Inc. Compounds for proteasome enzyme inhibition
US8143375B2 (en) * 2006-10-20 2012-03-27 The Governing Council Of The University Of Toronto Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation

Also Published As

Publication number Publication date
ES2634431T3 (es) 2017-09-27
CN102498124B (zh) 2015-05-13
CA2756804C (en) 2020-12-22
PT2408802T (pt) 2017-08-03
EP2408802B1 (en) 2017-05-03
EP2408802A4 (en) 2013-04-17
CN102498124A (zh) 2012-06-13
WO2010105363A1 (en) 2010-09-23
AU2010225426B2 (en) 2015-09-03
US10385099B2 (en) 2019-08-20
US20120065366A1 (en) 2012-03-15
US9260479B2 (en) 2016-02-16
AU2010225426A1 (en) 2011-10-13
JP5866277B2 (ja) 2016-02-17
US20160222062A1 (en) 2016-08-04
CA2756804A1 (en) 2010-09-23
EP2408802A1 (en) 2012-01-25
HK1172036A1 (en) 2013-04-12
JP2012520330A (ja) 2012-09-06
AU2010225426A8 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
DK2408802T3 (da) Cykliske aminosyremolekyler og fremgangsmåder til fremstilling heraf
Tavecchia et al. Degradation studies of antibiotic MDL 62,879 (GE2270A) and revision of the structure
CN109071430A (zh) 环肽的片段合成
Dietrich et al. Application of tandem Ugi multi-component reaction/ring closing metathesis to the synthesis of a conformationally restricted cyclic pentapeptide
Banfi et al. Passerini reaction–Amine Deprotection–Acyl Migration (PADAM): a convenient strategy for the solid-phase preparation of peptidomimetic compounds
Müntener et al. Synthesis of chiral nine and twelve-membered cyclic polyamines from natural building blocks
Maryanoff et al. Cyclotheonamide derivatives: Synthesis and thrombin inhibition. Exploration of specific structure-function issues
CA3170633A1 (en) Efficient preparation of dolastatin and auristatin analogs through a common intermediate
WO2011150499A1 (en) A method to insert molecular fragments into cyclic molecules
Avula et al. Stereoselective Synthesis of Southern Fragment of Hantupeptin-A
Zhang et al. Total synthesis and reassignment of stereochemistry of obyanamide
CN112334454B (zh) 环保的烯烃水合反应
Remete et al. Stereocontrolled synthesis of fluorine-containing functionalized β-lactam derivatives through cross-metathesis reactions
Hosseini et al. Pyrrolidinone-modified di-and tripeptides: highly diastereoselective preparation and investigation of their stability
Sohora et al. Synthesis and photochemical reactivity of phthalimidoadamantane–tyrosine conjugates
WO2012109735A1 (en) Methods of preparing cyclic amino acid molecules using arylboronic or arylborinic acid catalysts
Nain Studies on the Effect of Lewis Acids on Fmoc Deprotection in Solution and Solid-Phase
Ramos Synthesis of Yaku'amide A Analogues and Progress Toward Synthesis of Virosine A
WO2024024965A1 (ja) Ｏ－置換セリン誘導体の製造方法
Cizio Total synthesis of beauvericin using dehydroamino acid residues to facilitate cyclization
CN118234729A (zh) 用于制备双环甘氨酸-脯氨酸化合物和其单环甘氨酸-脯氨酸中间体的方法
Abdelraheem Exploitation of macrocyclic chemical space by multicomponent reaction (MCR) and their applications in medicinal chemistry
Gan et al. Concise and efficient total syntheses o f virenamides A and D, J
von Nussbaum et al. Supplementary Information Structure and Total Synthesis of Lysobactin (Katanosin B)
Courtemanche Bioactive Cyclic Peptides and Chemical Probes